Published in Nat Clin Pract Urol on January 01, 2009
Urological aspects of HIV and AIDS. Nat Rev Urol (2013) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS (2000) 8.94
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS (2002) 5.67
The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet (2002) 5.53
Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11
A possible explanation for heterosexual male infection with AIDS. N Engl J Med (1986) 3.68
Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol (2002) 3.66
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr (2008) 3.44
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1992) 3.00
Human papillomaviruses. Annu Rev Microbiol (1994) 2.88
Potential HIV-1 target cells in the human penis. AIDS (2006) 2.84
Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS (2006) 2.83
HIV-related nephropathy: a South African perspective. Kidney Int (2006) 2.46
Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect (2006) 2.25
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10
Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology (1994) 2.05
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2. Genitourin Med (1997) 1.94
Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol (2002) 1.90
EAU guidelines for the management of genitourinary tuberculosis. Eur Urol (2005) 1.87
Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol (1993) 1.70
The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS (2005) 1.65
Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. Int J Tuberc Lung Dis (2006) 1.62
Advanced penile carcinoma. J Urol (2003) 1.47
The urological management of the patient with acquired immunodeficiency syndrome. BJU Int (2005) 1.45
Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients. AIDS (1999) 1.42
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS (2008) 1.33
Fournier's gangrene in a modern surgical setting: improved survival with aggressive management. BJU Int (1999) 1.29
AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol (2008) 1.28
HIV care and the incidence of acute renal failure. Clin Infect Dis (2008) 1.18
Hyperbaric oxygen for the treatment of fournier's gangrene. J Urol (2005) 1.13
Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg (2003) 1.09
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer (2002) 1.07
A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS (2005) 1.07
The etiology of urolithiasis in HIV infected patients. J Urol (2003) 1.06
Urogenital tuberculosis in immunocompromised patients. Int Urol Nephrol (2008) 1.04
Increasing incidence and importance of HIV/AIDS and gonorrhea among men aged >/= 50 years in the US in the era of erectile dysfunction therapy. Scand J Urol Nephrol (2004) 1.04
Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS (2004) 1.04
Urinary stones in HIV-1-positive patients treated with indinavir. Lancet (1997) 1.04
Substance use, medications for sexual facilitation, and sexual risk behavior among traveling men who have sex with men. Sex Transm Dis (2006) 1.02
Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Curr HIV/AIDS Rep (2008) 1.02
HIV and prostate cancer: a systematic review of the literature. Prostate Cancer Prostatic Dis (2008) 1.02
Prognostic factors in Fournier gangrene. Int J Urol (2005) 1.01
Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med (2003) 1.01
Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol (2008) 1.00
The urological manifestations of the acquired immunodeficiency syndrome. J Urol (1989) 0.99
Urinary tract infections in HIV disease. Int J Antimicrob Agents (1999) 0.98
Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology (2000) 0.97
Fournier's gangrene: a retrospective clinical study on forty-one patients. ANZ J Surg (2005) 0.97
Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India. Nephron Clin Pract (2008) 0.97
How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep (2006) 0.96
Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr (2002) 0.96
HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management. Expert Rev Anti Infect Ther (2008) 0.95
Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus. J Urol (1999) 0.94
Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS (1992) 0.94
Correlation of CD4 counts with renal disease in HIV positive patients. Saudi J Kidney Dis Transpl (2008) 0.93
Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates. Transplantation (2008) 0.93
Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus. Urology (2005) 0.92
Lecture 5: erectile dysfunction in the HIV-positive male: a review of medical, legal and ethical considerations in the age of oral pharmacotherapy. Int J Impot Res (2000) 0.92
Protease inhibitor-induced urolithiasis. Urology (1997) 0.92
High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS (2006) 0.91
Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens (2006) 0.90
Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients. Hum Psychopharmacol (2007) 0.90
Squamous cell carcinoma of the scrotum associated with human papillomaviruses. J Urol (1993) 0.89
Pathologic aspects of AIDS malignancies. Oncogene (2003) 0.88
Below the belt: new insights into potential complications of HIV-1/schistosome coinfections. Curr Opin Infect Dis (2007) 0.88
Nosocomial infections among HIV-positive and HIV-negative patients in a Brazilian infectious diseases unit. Am J Infect Control (2002) 0.88
Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev (2007) 0.87
Urethral condyloma acuminata following urethral instrumentation in an elderly man. Int J Urol (2004) 0.86
Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists. Cancer Detect Prev (2006) 0.85
The impact of HIV infection on tropical diseases. Infect Dis Clin North Am (2005) 0.85
Protease inhibitors and erectile dysfunction. AIDS (2001) 0.85
Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS (2006) 0.85
Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol (1989) 0.84
HIV-AIDS: urologic considerations. Urol Clin North Am (2008) 0.84
Expression of DC-SIGN in human foreskin may facilitate sexual transmission of HIV. J Clin Pathol (2004) 0.83
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults. Ther Drug Monit (2007) 0.83
Micturition disturbances and human immunodeficiency virus infection. J Urol (1996) 0.83
Drug insight: testosterone preparations. Nat Clin Pract Urol (2006) 0.82
Analysis of the scientific literature on male circumcision and risk for HIV infection. Int J STD AIDS (1999) 0.82
Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Infection (2005) 0.82
Urolithiasis associated with the protease inhibitor indinavir. Urology (1997) 0.82
Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2006) 0.82
Human papillomavirus assay in genital warts--correlation with symptoms. Int J STD AIDS (2007) 0.81
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis (1999) 0.81
Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Expert Opin Drug Saf (2008) 0.81
Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod (2004) 0.81
Indinavir nephropathy. N Engl J Med (1997) 0.81
Malignancies in HIV: pre- and post-highly active antiretroviral therapy. J Natl Med Assoc (2008) 0.80
Urologic manifestations of AIDS. Urology (1987) 0.80
The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int (2001) 0.80
Indinavir urolithiasis. Curr Opin Urol (2000) 0.79
Voiding problems in patients with HIV infection and AIDS. Scand J Urol Nephrol (1995) 0.78
Prostatic tuberculosis in an HIV infected male. Sex Transm Infect (2002) 0.78